ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated
By Elana Gotkine HealthDay Reporter
FRIDAY, Oct. 25, 2024 -- Many anaphylaxis protocols are incomplete and/or outdated, and there is a need for patient education regarding treatment of anaphylaxis, according to two studies presented at the annual meeting of the American College of Allergy, Asthma & Immunology, held from Oct. 24 to 28 in Boston.
Carly Gunderson, D.O., from the Baylor College of Medicine in San Antonio, and colleagues reviewed allergic reaction and/or anaphylaxis protocols for 30 states with mandatory or model state-wide Advanced Cardiac Life Support protocols. The researchers found that only 50 and 40 percent of the states included gastrointestinal symptoms and neurological manifestations, respectively, in the definition of anaphylaxis. A two-organ system definition was used by 47 percent. All of the protocols recommended diphenhydramine and epinephrine for anaphylactic reactions. If respiratory symptoms were present, 90, 73, and 60 percent recommended albuterol, intravenous fluids, and steroids, respectively. In 97 percent of protocols, epinephrine was the first-line recommendation for anaphylaxis.
Joni Chow, D.O., also from the Baylor College of Medicine, and colleagues surveyed 96 patients/caregivers in the waiting room of an allergy clinic to assess knowledge of anaphylaxis. The researchers found that 95.8 percent of respondents were prescribed epinephrine. Overall, 14 percent correctly identified symptoms requiring epinephrine, although 73 percent agreed or strongly agreed with feeling comfortable with recognizing anaphylaxis symptoms. Almost one-quarter (23.7 percent) would treat with antihistamine first during an anaphylactic episode, although 85 percent stated that antihistamines do not prevent the need for epinephrine.
"The results demonstrate the need for better education of allergy patients to recognize and treat anaphylaxis appropriately," Chow said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Two-Hour Observation Probably Safe for Most Children With Anaphylaxis
THURSDAY, June 26, 2025 -- For most children who present to an emergency department with an acute allergic reaction requiring epinephrine, a two-hour observation period is...
Parents Delaying Introduction of Nuts and Eggs, Tied to Increase in Food Allergy Risk
WEDNESDAY, June 11, 2025 -- Most highly allergenic foods are introduced to infants at 6 to 9 months, but introduction of eggs and nuts is delayed beyond age 1 year in a large...
Peanut Oral Immunotherapy Efficacious in Allergic Adults
THURSDAY, May 1, 2025 -- Peanut oral immunotherapy (OIT) is efficacious for adults with peanut allergy, according to a study published online April 23 in Allergy. Hannah Hunter...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.